Chardan Reiterates Sell On Esperion, Cites 'Lack Of Visibility' And 'Possibility Of Declining Efficacy'
July 28, 2015 at 11:52 AM EDT
In a report published Tuesday, Chardan Capital Markets analyst Gbola Amusa reiterated a Sell rating on shares of Esperion ...